Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 620 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

Telik Q3 net loss narrows

Loss from operations for third quarter of 2012 was $1.88m compared to loss from operations of $2.85m for the third quarter of 2011. The company reported a net

Grünenthal, Amura sign new research deal

Pursuant to the agreement, the companies will work together to develop cathepsin inhibitors that play a vital role in pain and inflammation. Grünenthal will support the development of

Navidea reports Q3 net loss

Loss from operations for third quarter of 2012 was $9.07m compared to loss from operations of $6.47m for the third quarter of 2011. The company reported a net

DKSH to provide services to Nong’s

Nong’s managing director Calvin Chan said Nong’s has been working with DKSH since ten years and have now extended the collaboration for another five years. ”Being a reliable

Ironwood submits IW-2143 IND application to FDA

The trial will further evaluate pharmacokinetic profile of the anti-anxiety drug candidate in healthy volunteers. Bionomics CEO and managing director Dr Deborah Rathjen said, "Ironwood has a strong